Login / Signup

Cerebral Oximetry Monitoring in Extremely Preterm Infants.

Mathias Lühr HansenAdelina PellicerSimon Hyttel-SørensenEbru ErgenekonTomasz SzczapaCornelia HagmannGunnar NaulaersJonathan MintzerMonica FumagalliGabriel DimitriouEugene DempseyJakub TkaczykGuoqiang ChengSiv FredlyAnne M HeuchanGerhard PichlerHans FuchsSaudamini NesargiGitte H HahnSalvador Piris-BorregasJan ŠircMiguel Alsina-CasanovaMartin StockerHilal OzkanKosmas SarafidisAndrew O HopperTanja KarenBeata Rzepecka-WeglarzSerife S OguzLuis ArruzaAsli C MemisogluRuth Del Rio FlorentinoMariana BasergaPierre MatonAnita C TruttmannIsabel de Las CuevasPeter AgergaardPamela ZafraLars BenderRyszard LauterbachChantal LecartJulie de BuystAfif El-KhuffashAnna CurleyOlalla O VaccarelloJan MiletinEvangelia PapathomaZachary VesoulisGiovanni VentoLuc CornetteLaura S LopezBeril YasaAnja KlamerMassimo AgostiOlivier BaudEmmanuele MastrettaMerih CetinkayaKaren McCallShujuan ZengEleftheria HatzidakiAgata BargielSylwia MarciniakXiaoyan GaoLin HuijiaLina ChalakLing YangShashidhar A RaoXin XuBegoña L GonzalezMaria WilinskaZhaoqing YinIwona Sadowska-KrawczenkoItziar Serrano-ViñualesBarbara Królak-OlejnikMarta M YbarraCatalina Morales-BetancourtPeter KorčekMarta Teresa-PalacioFabio MoscaAnja HergenhanNilgun KoksalKonstantia TsoniMunaf M KadriClaudia KnöpfliElzbieta Rafinska-WaznyMustafa S AkinTone NordvikZhang PengSinem G KersinLiesbeth ThewissenAna AlarconDavid HealyBerndt UrlesbergerMünevver BaşJana BaumgartnerEleni SkylogianniVeronika KaradyovaEva ValverdeElena Bergon-SendinJachym KuceraSilvia PisoniLe WangAnne SmitsRebeca Sanchez-SalmadorMarie I RasmussenMarkus H OlsenAksel K JensenChristian GluudJanus C JakobsenGorm Greisen
Published in: The New England journal of medicine (2023)
In extremely preterm infants, treatment guided by cerebral oximetry monitoring for the first 72 hours after birth was not associated with a lower incidence of death or severe brain injury at 36 weeks' postmenstrual age than usual care. (Funded by the Elsass Foundation and others; SafeBoosC-III ClinicalTrials.gov number, NCT03770741.).
Keyphrases